Cargando…

Induction of Therapeutic Protection in an HPV16-Associated Mouse Tumor Model Through Targeting the Human Papillomavirus-16 E5 Protein to Dendritic Cells

HPV E5 is an oncoprotein mainly expressed in premalignant lesions, which makes it an important target for a vaccine to prevent or cure cervical cancer (CC). In this study, we evaluated whether E5 targeted to DEC-205, present in dendritic cells (DCs), could induce a therapeutic protection against HPV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badillo-Godinez, Oscar, Pedroza-Saavedra, Adolfo, Valverde-Garduño, Veronica, Bermudez-Morales, Victor, Maldonado-Gama, Minerva, Leon-Letelier, Ricardo, Bonifaz, Laura C., Esquivel-Guadarrama, Fernando, Gutierrez-Xicotencatl, Lourdes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947241/ https://www.ncbi.nlm.nih.gov/pubmed/33717073 http://dx.doi.org/10.3389/fimmu.2021.593161

Ejemplares similares

Validation of Serological Antibody Profiles Against Human Papillomavirus Type 16 Antigens as Markers for Early Detection of Cervical Cancer
por: Salazar-Piña, Dolores Azucena, et al.
Publicado: (2016)

Differential Antibody Response against Conformational and Linear Epitopes of the L1 Proteins from Human Papillomavirus Types 16/18 Is Observed in Vaccinated Women or with Uterine Cervical Lesions
por: Pedroza-Saavedra, Adolfo, et al.
Publicado: (2021)

Different Isoforms of HPV-16 E7 Protein are Present in Cytoplasm and Nucleus
por: Valdovinos-Torres, H, et al.
Publicado: (2008)

The Immune Response Generated against HPV Infection in Men and Its Implications in the Diagnosis of Cancer
por: Chihu-Amparan, Lilia, et al.
Publicado: (2023)

The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination
por: Antonio-Herrera, Laura, et al.
Publicado: (2018)

Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China
por: He, Hongchang, et al.
Publicado: (2016)

Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens
por: Lee, Sin Hang, et al.
Publicado: (2009)

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Fontan, Christian T., et al.
Publicado: (2020)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma
por: Martins, Sandra F., et al.
Publicado: (2020)

Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda
por: Waddell, K, et al.
Publicado: (2003)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Prevalence of Human Papillomavirus (HPV)-16 in Different Dental Infections in the Lebanese Population
por: Khalil, Wael, et al.
Publicado: (2023)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants
por: Rodríguez-Ruiz, Hugo Alberto, et al.
Publicado: (2019)

Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes
por: Gyöngyösi, Eszter, et al.
Publicado: (2012)

Analysis of Human Papillomavirus (HPV) 16 Variants Associated with Cervical Infection in Italian Women
por: Martinelli, Marianna, et al.
Publicado: (2020)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
por: Kohli, Michele, et al.
Publicado: (2012)

A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women
por: Tornesello, ML, et al.
Publicado: (2009)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
por: Sung, Yeoun Eun, et al.
Publicado: (2016)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

p53 Is Regulated in a Biphasic Manner in Hypoxic Human Papillomavirus Type 16 (HPV16)-Positive Cervical Cancer Cells
por: Zhuang, Linhan, et al.
Publicado: (2020)

Characterization of the Human Papillomavirus 16 Oncogenes in K14HPV16 Mice: Sublineage A1 Drives Multi-Organ Carcinogenesis
por: Cochicho, Daniela, et al.
Publicado: (2022)

Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis
por: Yang, Ruwen, et al.
Publicado: (2019)

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population
por: Marais, Dianne J, et al.
Publicado: (2006)

Frequency of Human Papillomavirus (HPV) 16 and 18 Detection in Paraffin- Embedded Laryngeal Carcinoma Tissue
por: Hosseini, Seyed Zinab, et al.
Publicado: (2017)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand
por: Khunamornpong, Surapan, et al.
Publicado: (2016)

Folate Repletion after Deficiency Induces Irreversible Genomic and Transcriptional Changes in Human Papillomavirus Type 16 (HPV16)-Immortalized Human Keratinocytes
por: Savini, Claudia, et al.
Publicado: (2019)

Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation
por: Hee Lee, Sung, et al.
Publicado: (2015)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Protective Antibodies Against Influenza Proteins
por: Padilla-Quirarte, Herbey O., et al.
Publicado: (2019)

The transcriptional regulator gene E2 of the Human Papillomavirus (HPV) 16 influences the radiosensitivity of cervical keratinocytes
por: Lindel, Katja, et al.
Publicado: (2012)

Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice
por: Whitehead, Mark, et al.
Publicado: (2014)

Human papillomavirus genotype and prognosis of cervical cancer: Favorable survival of patients with HPV16-positive tumors
por: Onuki, Mamiko, et al.
Publicado: (2018)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Peng, Shiwen, et al.
Publicado: (2021)

The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples
por: Song, Fangbin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agv1nl2jjtvr30et2l81ei5oki